RMTI Projected Dividend Yield
Rockwell Medical, Inc ( NASDAQ : RMTI )Rockwell Medical is a commercial-stage, biopharmaceutical company developing and commercializing its parenteral iron technology platform, Ferric Pyrophosphate Citrate (FPC). Co. is also a supplier of hemodialysis concentrate products to kidney dialysis clinics in the U.S. Co. has two therapies, Triferic and Triferic AVNU, which are developed from its FPC platform. Co. markets both products to kidney dialysis centers for their patients receiving dialysis. Co. has filed an Investigational New Drug Application to conduct a Phase II trial for the treatment of iron deficiency anemia in patients outside of dialysis, who are receiving intravenous medications in the home infusion setting. 20 YEAR PERFORMANCE RESULTS |
RMTI Dividend History Detail RMTI Dividend News RMTI Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |